These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11459875)

  • 1. Chemoprevention or antichemoprevention? A salutary warning From the beta-carotene experience.
    Paolini M; Abdel-Rahman SZ; Cantelli-Forti G; Legator MS
    J Natl Cancer Inst; 2001 Jul; 93(14):1110-1. PubMed ID: 11459875
    [No Abstract]   [Full Text] [Related]  

  • 2. Reflections on the landmark studies of beta-carotene supplementation.
    Duffield-Lillico AJ; Begg CB
    J Natl Cancer Inst; 2004 Dec; 96(23):1729-31. PubMed ID: 15572749
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy trial.
    Challem JJ
    J Natl Cancer Inst; 1997 Feb; 89(4):325-6. PubMed ID: 9048840
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-carotene and lung cancer: a lesson for future chemoprevention investigations?
    Greenwald P
    J Natl Cancer Inst; 2003 Jan; 95(1):E1. PubMed ID: 12509411
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Barnhart S; Balmes J; Cherniack M; Cullen M; Glass A; Keogh J; Liu D; Meyskens F; Perloff M; Valanis B; Williams J
    IARC Sci Publ; 1996; (136):67-85. PubMed ID: 8791118
    [No Abstract]   [Full Text] [Related]  

  • 6. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff.
    Goodman GE; Omenn GS
    Adv Exp Med Biol; 1992; 320():137-40. PubMed ID: 1442278
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoprevention of lung cancer is proving difficult and frustrating, requiring new approaches.
    Omenn GS
    J Natl Cancer Inst; 2000 Jun; 92(12):959-60. PubMed ID: 10861300
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
    J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial.
    Cullen MR; Barnett MJ; Balmes JR; Cartmel B; Redlich CA; Brodkin CA; Barnhart S; Rosenstock L; Goodman GE; Hammar SP; Thornquist MD; Omenn GS
    Am J Epidemiol; 2005 Feb; 161(3):260-70. PubMed ID: 15671258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarettes: a smoking gun in cancer chemoprevention.
    Mayne ST; Lippman SM
    J Natl Cancer Inst; 2005 Sep; 97(18):1319-21. PubMed ID: 16174848
    [No Abstract]   [Full Text] [Related]  

  • 13. An intervention trial in high-risk asbestos-exposed persons.
    McLarty JW
    Adv Exp Med Biol; 1992; 320():141-9. PubMed ID: 1442279
    [No Abstract]   [Full Text] [Related]  

  • 14. Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.
    de Klerk NH; Musk AW; Ambrosini GL; Eccles JL; Hansen J; Olsen N; Watts VL; Lund HG; Pang SC; Beilby J; Hobbs MS
    Int J Cancer; 1998 Jan; 75(3):362-7. PubMed ID: 9455794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Natural' cancer prevention trial halted.
    Peterson K
    Science; 1996 Jan; 271(5248):441. PubMed ID: 8560251
    [No Abstract]   [Full Text] [Related]  

  • 16. beta-Carotene and the risk of lung cancer.
    Pastorino U
    J Natl Cancer Inst; 1997 Mar; 89(6):456-7; author reply 457-8. PubMed ID: 9091650
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of lung cancer.
    Goodman GE
    Crit Rev Oncol Hematol; 2000 Mar; 33(3):187-97. PubMed ID: 10789492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Leo MA; Lieber CS
    J Natl Cancer Inst; 1997 Nov; 89(22):1722-3. PubMed ID: 9390543
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
    Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
    J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
    Omenn GS
    Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.